title: Rheumatoid nodules in systemic lupus erythematosus: a case report.
authors.forename: Hasna
authors.initials: H
authors.lastname: Hassikou
authors.forename: Fabienne
authors.initials: F
authors.lastname: Le Guilchard
authors.forename: Eric
authors.initials: E
authors.lastname: Lespessailles
authors.forename: Claude Laurent
authors.initials: CL
authors.lastname: Benhamou
authors.forename: Ludovic
authors.initials: L
authors.lastname: Martin
authors.forename: Remy
authors.initials: R
authors.lastname: Kerdraon
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D008775:Methylprednisolone / Q000627:therapeutic use; D012218:Rheumatoid Nodule / Q000150:complications* / Q000503:physiopathology; D016896:Treatment Outcome; D016312:Treatment Refusal
chemical_list: D018501:Antirheumatic Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone